The origin of the hypertensive effect of arecoline in rats.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002628:Chemoreceptor Cells / Q000187:drug effects; D003042:Cocaine / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006973:Hypertension / Q000139:chemically induced*; D007022:Hypotension / Q000139:chemically induced; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008297:Male; D009538:Nicotine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D014628:Vagotomy; D014630:Vagus Nerve / Q000502:physiology
D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D010276:Parasympatholytics; D001115:Arecoline; D009538:Nicotine; D001285:Atropine; D012110:Reserpine; D003042:Cocaine